1
|
Zheng F, Annamma LM, Harikrishnan SS, Lee DJ. Systemic Factors Affecting Prognosis in Restorative and Prosthetic Dentistry: A Review. Dent Clin North Am 2024; 68:751-765. [PMID: 39244255 DOI: 10.1016/j.cden.2024.05.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/09/2024]
Abstract
The field of restorative and prosthetic dentistry focuses on restoring lost tooth structures and replacing missing teeth and lost tissue to restore or improve esthetics and oral health. Many systemic factors such as metabolic, bone, autoimmune, cardiovascular, and endocrine disorders can affect healing procedures, and bone density and impact oral health. Hence patients suffering from systemic disease when treated for prosthodontic rehabilitation can have negative prognostic outcomes. The commonest prosthodontic treatments that can be affected include dental implants, fixed prostheses, and removable prostheses. Understanding and managing these systemic factors play a key role in the success of prosthodontic treatment.
Collapse
Affiliation(s)
- Fengyuan Zheng
- Advanced Education Program in Prosthodontics, Department of Restorative Sciences, Division of Prosthodontics, University of Minnesota School of Dentistry, 9-176 Moos Tower, 515 Delaware Street Southeast, Minneapolis, MN 55455, USA
| | - Lovely Muthiah Annamma
- College of Dentistry, Ajman University, PO Box 346, University Street Al Jeft 1, Ajman, United Arab Emirates
| | | | - Damian J Lee
- Department of Prosthodontics, Tufts University School of Dental Medicine, 1 Kneeland Street, DHS 220; Boston, MA 02111, USA.
| |
Collapse
|
2
|
Bala S, Kumari R. Assessment of Effect of Periodontal and Prosthodontic Therapy on Glycemic Control in Patients with Diabetes. J Pharm Bioallied Sci 2021; 13:S1561-S1563. [PMID: 35018029 PMCID: PMC8686928 DOI: 10.4103/jpbs.jpbs_286_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 05/02/2021] [Accepted: 05/06/2021] [Indexed: 11/04/2022] Open
Abstract
BACKGROUND Periodontitis is a chronic inflammatory disease of multifactorial etiology. The present study was conducted to assess the effect of periodontal and prosthodontic therapy on glycemic control in patients with diabetes. MATERIALS AND METHODS 80 type II diabetics patients of both genders were divided into Group I (periodontal and prosthodontic therapy) and Group II (Healthy). In control group, only oral hygiene instruction and mouth wash were prescribed. RESULTS Group I had 22 males and 18 females and Group II had 17 males and 23 females. The mean glycated hemoglobin level in Group I was 7.8% before and 6.7% after treatment and in Group II was 6.4% before and 6.2% after treatment. The difference was significant (P < 0.05). CONCLUSION There was improvement in glycemic status in diabetic patients undergoing periodontal and prosthodontic therapy as compared to those not undergoing treatment.
Collapse
Affiliation(s)
- Suman Bala
- Department of Physiology, Government Medical College, Doda, Jammu and Kashmir, India
| | - Ranjna Kumari
- Department of Prosthodontics and Crown and Bridge, Desh Bhagat Dental College and Hospital, Mandi Gobindgarh, Punjab, India,Address for correspondence: Dr. Ranjna Kumari, Department of Prosthodontics and Crown and Bridge, Desh Bhagat Dental College and Hospital, Mandi Gobindgarh, Punjab, India. E-mail:
| |
Collapse
|
3
|
Overmyer KA, Rhoads TW, Merrill AE, Ye Z, Westphall MS, Acharya A, Shukla SK, Coon JJ. Proteomics, lipidomics, metabolomics and 16S DNA sequencing of dental plaque from patients with diabetes and periodontal disease. Mol Cell Proteomics 2021; 20:100126. [PMID: 34332123 PMCID: PMC8426274 DOI: 10.1016/j.mcpro.2021.100126] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2021] [Accepted: 07/24/2021] [Indexed: 12/11/2022] Open
Abstract
Oral microbiome influences human health, specifically prediabetes and type 2 diabetes (Pre-DM/DM) and periodontal diseases (PDs), through complex microbial interactions. To explore these relations, we performed 16S rDNA sequencing, metabolomics, lipidomics, and proteomics analyses on supragingival dental plaque collected from individuals with Pre-DM/DM (n = 39), Pre-DM/DM and PD (n = 37), PD alone (n = 11), or neither (n = 10). We identified on average 2790 operational taxonomic units and 2025 microbial and host proteins per sample and quantified 110 metabolites and 415 lipids. Plaque samples from Pre-DM/DM patients contained higher abundance of Fusobacterium and Tannerella than plaques from metabolically healthy patients. Phosphatidylcholines, plasmenyl phosphatidylcholines, ceramides containing non-OH fatty acids, and host proteins related to actin filament rearrangement were elevated in plaques from PD versus non-PD samples. Cross-omic correlation analysis enabled the detection of a strong association between Lautropia and monomethyl phosphatidylethanolamine (PE-NMe), which is striking because synthesis of PE-NMe is uncommon in oral bacteria. Lipidomics analysis of in vitro cultures of Lautropia mirabilis confirmed the synthesis of PE-NMe by the bacteria. This comprehensive analysis revealed a novel microbial metabolic pathway and significant associations of host-derived proteins with PD. Patients with periodontal disease or diabetes have unique microbial dysbiosis. Proteomics and 16S data provide complementary information about microbial diversity. Cross-omic correlation reveals host signatures associated with periodontal disease. Multi-omic data lead to finding about microbially synthesized lipids.
Collapse
Affiliation(s)
- Katherine A Overmyer
- Morgridge Institute for Research, Madison, WI 53715, USA; Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA; National Center for Quantitative Biology of Complex Systems, Madison, WI 53706, USA
| | - Timothy W Rhoads
- Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - Anna E Merrill
- Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - Zhan Ye
- Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI 54449, USA
| | - Michael S Westphall
- Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA; National Center for Quantitative Biology of Complex Systems, Madison, WI 53706, USA
| | - Amit Acharya
- Center for Oral and Systemic Health, Marshfield Clinic, Marshfield, WI 54449, USA
| | - Sanjay K Shukla
- Center for Oral and Systemic Health, Marshfield Clinic, Marshfield, WI 54449, USA; Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI 54449, USA.
| | - Joshua J Coon
- Morgridge Institute for Research, Madison, WI 53715, USA; Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA; Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA; National Center for Quantitative Biology of Complex Systems, Madison, WI 53706, USA.
| |
Collapse
|